AbbVie Issues Inaugural Full-Year Outlook for 2013

Published: Jan 30, 2013

AbbVie today confirmed it delivered strong sales growth with its marketed pharmaceutical products in 2012. The proprietary pharmaceutical segment of Abbott, representing the majority of AbbVie's revenue, grew more than 8 percent globally on an operational basis, excluding a nearly 3 percent negative impact from foreign exchange.

Back to news